Northern Trust’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

Northern Trust’s Portfolio GRNA Stock Details GRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-164,140	Closed	-$48.9K	–	4598
2023 Q2	$48.9K	Sell	164,140 -556,749	-77%	-$168K	﹤0.01%	4227
2023 Q1	$312K	Sell	720,889 -45,721	-6%	-$35.1K	﹤0.01%	3652
2022 Q4	$905K	Buy	766,610 +167,226	+28%	+$272K	﹤0.01%	3296
2022 Q3	$1.39M	Buy	599,384 +389,278	+185%	+$1.02M	﹤0.01%	3183
2022 Q2	$465K	Buy	210,106 +105,625	+101%	+$732K	﹤0.01%	3561
2022 Q1	$1.01M	Buy	+104,481	New	+$936K	﹤0.01%	3415

Northern Trust's GRNA Position: Q3 2023 in Review

Northern Trust sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q3 2023, closing a stake of 164,140 shares — an estimated $48.9K sold.

Northern Trust first reported a position in GRNA in Q1 2022 and held it in 6 quarters. The position peaked at $1.39M in Q3 2022. 0 funds tracked by Wall St. Rank hold GRNA as of Q3 2023.

Northern Trust reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q3 2023 after selling out during the quarter.
Northern Trust sold 164,140 GreenLight Biosciences Holdings, PBC Common Stock shares in Q3 2023, an estimated $48.9K.
Northern Trust first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q1 2022 and held it in 6 quarters.
Northern Trust's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $1.39M in Q3 2022.
0 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.